Sam Lee's most recent trade in Cocrystal Pharma Inc was a trade of 40,000 Common Stock done . Disclosure was reported to the exchange on Oct. 9, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cocrystal Pharma Inc | Sam Lee | President and Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Oct 2024 | 40,000 | 76,355 (0%) | 0% | - | Common Stock | |
| Cocrystal Pharma Inc | Sam Lee | President and Co-CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2023 | 30,000 | 30,000 | - | - | Stock Options (Right to Buy) | |
| Cocrystal Pharma Inc | Sam Lee | President and Co-Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jul 2022 | 300,000 | 300,000 | - | - | Stock Options (Right to Buy) | |
| Cocrystal Pharma Inc | Sam Lee | President and Co-Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jul 2021 | 250,000 | 250,000 | - | - | Stock Options (Right to Buy) |